Nkgen Biotech Inc (NKGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 0 | 0 | 0 | 74 | 3 |
| Gross Profit | N/A | N/A | N/A | 56 | 3 |
| Operating Expenses | 6,903 | 6,611 | 6,798 | 16,727 | 5,995 |
| Operating Income | -6,903 | -6,611 | -6,798 | -16,653 | -5,992 |
| Interest Expense | 211 | 62 | 34 | 1,670 | 636 |
| Other Income | -26,063 | -1,176 | -1,490 | -4,675 | -65 |
| Pre-tax Income | -33,177 | -7,849 | -8,322 | -22,998 | -6,693 |
| Income Tax | N/A | N/A | N/A | 8 | N/A |
| Net Income Continuous | -33,177 | -7,849 | -8,322 | -23,007 | -6,693 |
| Net Income | $-33,177 | $-7,849 | $-8,322 | $-23,007 | $-6,693 |
| EPS Basic Total Ops | -2.48 | -0.59 | -0.63 | -3.24 | -1.10 |
| EPS Basic Continuous Ops | -2.48 | -0.59 | -0.63 | -3.25 | -1.10 |
| EPS Diluted Total Ops | -2.48 | -0.59 | -0.63 | -3.24 | -1.10 |
| EPS Diluted Continuous Ops | -2.48 | -0.59 | -0.63 | -3.25 | -1.10 |
| EPS Diluted Before Non-Recurring Items | -2.48 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,603 | $-6,312 | $-6,494 | $-16,347 | $-5,992 |